scyllo-inositol Completed Phase 2 Trials for Alzheimer's Disease (AD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00568776ELND005 in Patients With Mild to Moderate Alzheimer's Disease
NCT01735630Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
NCT00934050ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease